Clamelle of Actavis awarded in the UK
Actavis was won the Best POM to P Switch of the Year Award for Clamelle at the annual SMaRT Awards last week in Birmingham, UK. The Clamelle training materials were also awarded Highly Commended in the Best Educational Initiative for Pharmacists category.
Sales, Marketing and Retail Training (SMaRT) Awards, which are sponsored by Numark, exist to acknowledge the excellence of training initiatives and sales and marketing support programmes provided by manufacturers to pharmacists and their staff.
Clamelle was awarded the title of Best POM to P switch in the pharmaceutical industry in 2008. Following the reclassification of azithromycin 500mg from prescription-only (POM) to pharmacy (P, OTC) medicine status, the Clamelle Chlamydia Test Kit and Clamelle Azithromycin 500mg tablets were launched in November 2008, under the banner of the Clamelle Chlamydia Service.
Competition in this category was fierce with Feminax Ultra (naproxen), Bayer and Voltarol (diclofenac), Novartis Consumer Health.
Excellent Educational Initiative
The Clamelle training materials which were prepared to support the launch of Clamelle were highly commended in this category. All UK pharmacists and pharmacy assistants received the training materials which were accredited by both NPA and CPP.
- Contact Information
- Hjordis Arnadottir
- Director, External Communications
- Actavis Group
- Contact via E-mail
This news content may be integrated into any legitimate news gathering and publishing effort. Linking is permitted.
News Release Distribution and Press Release Distribution Services Provided by WebWire.